Luca Issi
Stock Analyst at RBC Capital
Total Price Targets
29
Stocks Covered
12
Sectors
Healthcare
Most Recent
Apr 8, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Luca Issi
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | $100.00 | $69.25 | +44.4% | 1 | Apr 8, 2026 |
| QURE | uniQure N.V. | $35.00 | $19.21 | +82.1% | 3 | Mar 9, 2026 |
| MRNA | Moderna, Inc. | $30.00 | $44.65 | -32.8% | 6 | Feb 17, 2026 |
| IONS | Ionis Pharmaceuticals, Inc. | $95.00 | $75.86 | +25.2% | 3 | Dec 17, 2025 |
| CRSP | CRISPR Therapeutics AG | $50.00 | $51.72 | -3.3% | 2 | Nov 11, 2025 |
| BMRN | BioMarin Pharmaceutical Inc. | $66.00 | $54.20 | +21.8% | 1 | Oct 28, 2025 |
| NTLA | Intellia Therapeutics, Inc. | $14.00 | $13.20 | +6.1% | 3 | Oct 28, 2025 |
| RGNX | REGENXBIO Inc. | $30.00 | $9.14 | +228.2% | 2 | Jan 7, 2025 |
| WVE | Wave Life Sciences Ltd. | $15.00 | $7.32 | +105.1% | 1 | Oct 21, 2024 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $300.00 | $297.62 | +0.8% | 5 | Aug 26, 2024 |
| MGTX | MeiraGTx Holdings plc | $9.00 | $9.46 | -4.8% | 1 | Aug 13, 2024 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $24.98 | $74.82 | -66.6% | 1 | May 30, 2024 |
Recent Activity
- Apr 8, 2026— Set$100.00price target onBBIO(BridgeBio Pharma, Inc.)
- Mar 9, 2026— Set$35.00price target onQURE(uniQure N.V.)
- Mar 2, 2026— Set$11.00price target onQURE(uniQure N.V.)
- Feb 17, 2026— Set$30.00price target onMRNA(Moderna, Inc.)
- Dec 17, 2025— Set$95.00price target onIONS(Ionis Pharmaceuticals, Inc.)
- Nov 21, 2025— Set$25.00price target onMRNA(Moderna, Inc.)
- Nov 11, 2025— Set$50.00price target onCRSP(CRISPR Therapeutics AG)
- Oct 28, 2025— Set$14.00price target onNTLA(Intellia Therapeutics, Inc.)
- Oct 28, 2025— Set$66.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Jan 7, 2025— Set$24.00price target onQURE(uniQure N.V.)
- Jan 7, 2025— Set$30.00price target onRGNX(REGENXBIO Inc.)
- Oct 21, 2024— Set$15.00price target onWVE(Wave Life Sciences Ltd.)
- Sep 13, 2024— Set$75.00price target onMRNA(Moderna, Inc.)
- Aug 26, 2024— Set$300.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- Aug 13, 2024— Set$9.00price target onMGTX(MeiraGTx Holdings plc)
- Aug 9, 2024— Set$54.00price target onNTLA(Intellia Therapeutics, Inc.)
- Aug 6, 2024— Set$60.00price target onCRSP(CRISPR Therapeutics AG)
- Aug 5, 2024— Set$90.00price target onMRNA(Moderna, Inc.)
- Jun 27, 2024— Set$265.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- Jun 25, 2024— Set$250.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Luca Issi?
Luca Issi is a stock analyst at RBC Capital covering 12 stocks primarily in Healthcare. They have issued 29 price targets since Feb 10, 2022.
What stocks does Luca Issi cover?
Luca Issi currently covers 12 stocks, including MRNA, ALNY, QURE, IONS, NTLA.
What is Luca Issi's latest price target?
Luca Issi's most recent price target was $100.00 on BBIO (BridgeBio Pharma, Inc.), set on Apr 8, 2026.
What is Luca Issi's highest price target?
Luca Issi's highest issued price target is $300.00 on ALNY, set on Aug 26, 2024.
More Analysts at RBC Capital
Coverage based on publicly published price targets. Not investment advice.